Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Eclipta alba flavonoids may help treat diabetes by effectively inhibiting Aldose reductase.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

The congress showed advancements in skin hydration, barrier function, and safe, effective new cosmetic formulations.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

A new method using solid-state circular dichroism anisotropy can distinguish similar chiral compounds better than traditional techniques.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Human liver enzyme DHEA ST helps process minoxidil.